About 2,180 results
Open links in new tab
Center for Biosimilars®
FDA Approves Celltrion and Teva's Trastuzumab Biosimilar, Herzuma
FDA Approves Idacio, the Eighth Adalimumab Biosimilar
FDA Approves Pfizer's Rituximab Biosimilar, Ruxience
EirGenix Trastuzumab Biosimilar Candidate Demonstrates …
FDA Approves Semglee Insulin Glargine as First Interchangeable …
Amgen 2020 Biosimilar Report Provides Market Share, ASP Info
First Dornase Alfa Biosimilar Approved and Launched in Russia
FDA Approves First Stelara Biosimilar, Wezlana - Center for …
FDA Releases Guidance on Biologic, Biosimilar, and …